Literature DB >> 15245455

How to avoid problems in redo coronary artery bypass surgery.

V R Machiraju1.   

Abstract

The objective of my presentation is to discuss the various intra- and perioperative problems related to redo coronary artery bypass surgery so that we can minimize complications during surgery and improve the final outcomes. When a patient accepts redo cardiac surgery in spite of known higher morbidity and mortality, the patient strongly believes that he will come out of this operation successfully and enjoy several more years of life. Weintraub reported that redo cardiac surgery has higher mortality and morbidity; 5% in elective cases, 11% in urgent cases, and 16.4% in emergency cases. He and associates described that the female gender, a low ejection fraction (EF), and preoperative arrhythmias are significant risk factors. Lemmer and associates described poor postoperative functional results with the majority of patients having emergency repeat coronary artery revascularization developing recurrent ischemic syndrome within a short period of time. I am outlining the problems from our experience of 543 patients in the last five years.

Entities:  

Mesh:

Year:  2004        PMID: 15245455     DOI: 10.1111/j.0886-0440.2004.4051_11.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  3 in total

1.  Redo coronary artery bypass grafting.

Authors:  Faisal G Bakaeen; Zade Akras; Lars G Svensson
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-02-17

2.  Combination of inductive effect of lipopolysaccharide and in situ mechanical conditioning for forming an autologous vascular graft in vivo.

Authors:  Chao-Lin Chen; How-Ran Guo; Ying-Jan Wang; Hong-Tai Chang; Chui-Yi Pan; Ho-Yi Tuan-Mu; Hsiu-Chuan Lin; Chao-Yi Chen; Jin-Jia Hu
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

Review 3.  Redo Coronary Artery Bypass Grafting in the era of Advanced PCI.

Authors:  Ter-Er Kusu-Orkar; Kellan Masharani; Amer Harky; Andrew D Muir
Journal:  Braz J Cardiovasc Surg       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.